- CiVax™ booster vaccine administered seven months after primary vaccination with COVID-19 adenovirus vaccine shows rapid enhancement of neutralizing antibody responses in non-human primates
- Neutralizing antibodies against Delta and original strain increased by up to 27-fold within one week and up to 243-fold within three weeks
- Omicron neutralizing antibody levels were undetectable prior to booster vaccination, and attained presumed protective levels within one week of vaccination
Xerox Awarded 10-Year, $164M Contract By USDA To Streamline Practices, Increase Innovation
The U.S. Department of Agriculture (USDA) has awarded Xerox a 10-year, $164M contract for continued Managed Print Services, new Electronic Fax Services (EFS) and additional innovation across its agencies. The contract